-
1.
公开(公告)号:US20230337977A1
公开(公告)日:2023-10-26
申请号:US18342551
申请日:2023-06-27
申请人: TWIN HEALTH, INC.
IPC分类号: A61B5/00 , G16H15/00 , A61B5/11 , A61B5/145 , G16H50/30 , G16H40/67 , G16H20/10 , G16H20/60 , G16H50/20 , G16H10/40 , G16H50/50 , G16H10/60 , G06N20/00
CPC分类号: A61B5/4866 , G16H15/00 , A61B5/7475 , A61B5/4833 , A61B5/1118 , A61B5/486 , A61B5/7275 , A61B5/14532 , A61B5/6802 , G16H50/30 , G16H40/67 , G16H20/10 , G16H20/60 , G16H50/20 , G16H10/40 , A61B5/742 , G16H50/50 , G16H10/60 , G06N20/00 , A61B5/7267 , A61B5/6801 , A61B5/749 , A61B5/0205
摘要: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform encodes the biosignals into a vector representation and inputs the vector representation into a patient-specific metabolic model to determine a metabolic state of the patient at a conclusion of the current time period. The patient-specific metabolic model comprises a set of parameter values determined based on labels assigned to the previous metabolic states and a function representing one or more effects of the plurality of biosignals of the personalized metabolic profile. The platform compares the determined metabolic state of the patient to a threshold metabolic state representing a target metabolism. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve the determined metabolic state to the functional metabolic state.
-
2.
公开(公告)号:US20230110674A1
公开(公告)日:2023-04-13
申请号:US17963933
申请日:2022-10-11
申请人: Twin Health, Inc.
IPC分类号: G16H10/20
摘要: A Digital Twin clinical trial simulator determines one or more trial parameters for a physical experiment to validate a candidate treatment recommendation. For each of one or more variations of the physical experiment, the Digital Twin clinical trial simulator determines an effectiveness of the variation in validating the candidate treatment recommendation. The effectiveness describes a likelihood that the physical experiment will provide insight regarding the effect of the candidate treatment recommendation on a metabolic state. For a variation that satisfies a threshold effectiveness, the Digital Twin clinical trial simulator determines one or more metabolic features shared among a cohort of patients sensitive to the candidate treatment recommendation. The Digital Twin clinical trial simulator generates instructions for a medical professional to perform a physical experiment by adjusting the trial parameters according to the selected variation and enrolling patients sharing at least one of the one or more metabolic features.
-
公开(公告)号:US20210045682A1
公开(公告)日:2021-02-18
申请号:US16993189
申请日:2020-08-13
申请人: TWIN HEALTH, INC.
IPC分类号: A61B5/00 , A61B5/11 , A61B5/145 , G16H50/30 , G16H40/67 , G16H20/10 , G16H20/60 , G16H50/20 , G16H10/40 , G16H15/00
摘要: A patient health management platform determines of a metabolic state for a first time period. The platform generates a patient-specific treatment recommendation for a second time period following the first time period that identifies objectives for the patient to complete to improve the metabolic state determined for the first time period. Periodically during the second time period, the platform receives recordings of patient data indicating foods consumed by the patient, medication taken by the patient, and/or symptoms experienced by the patient. The platform compares the received recordings of patient data from the second time period to the generated patient-specific treatment recommendation to determine a number of objectives completed by the patient and updates a score representing n adherence of the patient to the patient-specific treatment recommendation based the number of completed objectives. The platform provides the patient-specific treatment recommendation to the patient device for display to the patient.
-
4.
公开(公告)号:US20240156404A1
公开(公告)日:2024-05-16
申请号:US18393360
申请日:2023-12-21
申请人: TWIN HEALTH, INC.
IPC分类号: A61B5/00 , A61B5/11 , A61B5/145 , G06N20/00 , G16H10/40 , G16H10/60 , G16H15/00 , G16H20/10 , G16H20/60 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50
CPC分类号: A61B5/4866 , A61B5/1118 , A61B5/14532 , A61B5/4833 , A61B5/486 , A61B5/6801 , A61B5/6802 , A61B5/7267 , A61B5/7275 , A61B5/742 , A61B5/7475 , A61B5/749 , G06N20/00 , G16H10/40 , G16H10/60 , G16H15/00 , G16H20/10 , G16H20/60 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , A61B5/0205
摘要: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform receives patient data recorded during the current time period comprising food items consumed, medications taken, and symptoms experienced by the patient. The platform implements a machine-learned metabolic model to determine a metabolic state of the patient at a conclusion of the current time period by comparing a true representation of the metabolic state and a prediction of the metabolic state. The true representation and the prediction are determined based on the recorded biosignals and the recorded patient data, respectively. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve their metabolic state and provides the patient-specific treatment recommendation to the patient device for display to the patient.
-
5.
公开(公告)号:US11723595B2
公开(公告)日:2023-08-15
申请号:US16993184
申请日:2020-08-13
申请人: TWIN HEALTH, INC.
IPC分类号: G16H15/00 , A61B5/00 , A61B5/11 , A61B5/145 , G16H50/30 , G16H40/67 , G16H20/10 , G16H20/60 , G16H50/20 , G16H10/40 , G16H50/50 , G16H10/60 , G06N20/00 , A61B5/0205
CPC分类号: A61B5/4866 , A61B5/1118 , A61B5/14532 , A61B5/486 , A61B5/4833 , A61B5/6801 , A61B5/6802 , A61B5/7267 , A61B5/7275 , A61B5/742 , A61B5/749 , A61B5/7475 , G06N20/00 , G16H10/40 , G16H10/60 , G16H15/00 , G16H20/10 , G16H20/60 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , A61B5/0205
摘要: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform encodes the biosignals into a vector representation and inputs the vector representation into a patient-specific metabolic model to determine a metabolic state of the patient at a conclusion of the current time period. The patient-specific metabolic model comprises a set of parameter values determined based on labels assigned to the previous metabolic states and a function representing one or more effects of the plurality of biosignals of the personalized metabolic profile. The platform compares the determined metabolic state of the patient to a threshold metabolic state representing a target metabolism. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve the determined metabolic state to the functional metabolic state.
-
公开(公告)号:US20210219910A1
公开(公告)日:2021-07-22
申请号:US17202352
申请日:2021-03-16
申请人: Twin Health, Inc.
IPC分类号: A61B5/00 , G16H15/00 , A61B5/11 , A61B5/145 , G16H50/30 , G16H40/67 , G16H20/10 , G16H20/60 , G16H50/20 , G16H10/40 , G16H50/50 , G16H10/60 , G06N20/00
摘要: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform receives patient data recorded during the current time period comprising food items consumed, medications taken, and symptoms experienced by the patient. The platform implements a machine-learned metabolic model to determine a metabolic state of the patient at a conclusion of the current time period by comparing a true representation of the metabolic state and a prediction of the metabolic state. The true representation and the prediction are determined based on the recorded biosignals and the recorded patient data, respectively. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve their metabolic state and provides the patient-specific treatment recommendation to the patient device for display to the patient.
-
7.
公开(公告)号:US20210045694A1
公开(公告)日:2021-02-18
申请号:US16993184
申请日:2020-08-13
申请人: TWIN HEALTH, INC.
IPC分类号: A61B5/00 , A61B5/145 , G16H50/50 , G16H40/67 , G16H10/40 , G16H50/30 , G16H20/60 , G16H10/60 , G06N20/00
摘要: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform encodes the biosignals into a vector representation and inputs the vector representation into a patient-specific metabolic model to determine a metabolic state of the patient at a conclusion of the current time period. The patient-specific metabolic model comprises a set of parameter values determined based on labels assigned to the previous metabolic states and a function representing one or more effects of the plurality of biosignals of the personalized metabolic profile. The platform compares the determined metabolic state of the patient to a threshold metabolic state representing a target metabolism. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve the determined metabolic state to the functional metabolic state.
-
8.
公开(公告)号:US20240331839A1
公开(公告)日:2024-10-03
申请号:US18623790
申请日:2024-04-01
申请人: Twin Health, Inc.
摘要: Disclosed herein is a method, system, and computer-readable medium for recommending foods to a patient. The disclosure includes accessing a record of food items recorded by a patient, including a classification of each food item. The method retrieves a current metabolic profile of the patient. Using a machine learning model, the method determines an updated classification for the food items and generates a notification for the patient. Additionally disclosed is a method, system, and computer-readable medium for recommending activities and activity times to a patient. The method includes accessing a record of activities previously recorded by a patient, each entry in the recordings including a duration of the activity and biosignal measurements. The method determines an effect of each activity on the metabolic state of the patient using a machine learning model. The method identifies activities that improve the patient's metabolic state and generates a recommendation for the patient.
-
公开(公告)号:US11957484B2
公开(公告)日:2024-04-16
申请号:US16993177
申请日:2020-08-13
申请人: TWIN HEALTH, INC.
IPC分类号: G16H20/60 , A61B5/00 , A61B5/11 , A61B5/145 , G06N20/00 , G16H10/40 , G16H10/60 , G16H15/00 , G16H20/10 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , A61B5/0205
CPC分类号: A61B5/4866 , A61B5/1118 , A61B5/14532 , A61B5/4833 , A61B5/486 , A61B5/6801 , A61B5/6802 , A61B5/7267 , A61B5/7275 , A61B5/742 , A61B5/7475 , A61B5/749 , G06N20/00 , G16H10/40 , G16H10/60 , G16H15/00 , G16H20/10 , G16H20/60 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , A61B5/0205
摘要: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform receives patient data recorded during the current time period comprising food items consumed, medications taken, and symptoms experienced by the patient. The platform implements a machine-learned metabolic model to determine a metabolic state of the patient at a conclusion of the current time period by comparing a true representation of the metabolic state and a prediction of the metabolic state. The true representation and the prediction are determined based on the recorded biosignals and the recorded patient data, respectively. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve their metabolic state and provides the patient-specific treatment recommendation to the patient device for display to the patient.
-
公开(公告)号:US11350876B2
公开(公告)日:2022-06-07
申请号:US17202354
申请日:2021-03-16
申请人: TWIN HEALTH, INC.
IPC分类号: A61B5/00 , G16H50/30 , G16H40/67 , G16H50/20 , G16H15/00 , A61B5/11 , A61B5/145 , G16H20/10 , G16H20/60 , G16H10/40 , G16H50/50 , G16H10/60 , G06N20/00 , A61B5/0205
摘要: A patient health management platform determines of a metabolic state for a first time period. The platform generates a patient-specific treatment recommendation for a second time period following the first time period that identifies objectives for the patient to complete to improve the metabolic state determined for the first time period. Periodically during the second time period, the platform receives recordings of patient data indicating foods consumed by the patient, medication taken by the patient, and/or symptoms experienced by the patient. The platform compares the received recordings of patient data from the second time period to the generated patient-specific treatment recommendation to determine a number of objectives completed by the patient and updates a score representing n adherence of the patient to the patient-specific treatment recommendation based the number of completed objectives. The platform provides the patient-specific treatment recommendation to the patient device for display to the patient.
-
-
-
-
-
-
-
-
-